Can Wegovy cause dehydration?
Wegovy (semaglutide) can lead to dehydration indirectly because it commonly causes gastrointestinal side effects such as nausea, vomiting and diarrhoea, which may result in fluid loss if not replaced promptly. UK clinical guidance notes that dehydration during treatment with GLP-1 receptor agonists can worsen kidney function and potentially lead to acute kidney injury, so patients should be advised to maintain adequate fluid intake when experiencing these side effects. The official product information for Wegovy warns that gastrointestinal reactions may cause dehydration and specifically recommends taking precautions to avoid fluid depletion. Mild dehydration is usually managed by increasing intake of water, clear broths or oral rehydration solutions, and reducing the severity of symptoms through dose adjustment or dietary measures. If signs of severe dehydration occur—such as dizziness, reduced urine output or rapid heartbeat—patients should seek medical advice promptly to prevent complications.
- Wegovy does not directly cause dehydration but may trigger it through side effects like nausea, vomiting and diarrhoea.
- Dehydration increases the risk of kidney problems, including acute kidney injury, in patients on GLP-1 receptor agonists.
- The Wegovy product leaflet advises patients to take precautions against fluid loss when experiencing gastrointestinal symptoms.
- Managing mild dehydration involves drinking plenty of water, clear broths or using oral rehydration solutions.
- Patients should monitor for severe dehydration signs—such as dizziness or low urine output—and seek medical help if these occur.